REG - Hikma Pharmaceutical - Director/PDMR Shareholding <Origin Href="QuoteRef">HIK.L</Origin>

Hikma PharmaceuticalsAnnouncement

23/03/2017 09:35

RNS Number : 3051A
Hikma Pharmaceuticals Plc
23 March 2017
Notification and public disclosure of transactions by persons discharging managerial responsibilities
The attached individual notification made under article 19.1 of the Market Abuse Regulation ("MAR") relates to the disposal of Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC by the Chief Strategy and Corporate Development Officer. This announcement is made in accordance with article 19.3 of MAR.
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Bassam Kanaan
2
Reason for the notification
a)
Position/status
Chief Strategy and Corporate Development Officer / PDMR
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Hikma Pharmaceuticals PLC
b)
LEI
549300BNS685UXH4JI75
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument and identification code
Description: Ordinary shares of 10 pence each
ID Code: GB00B0LCW083
b)
Nature of the transaction
Disposal of 43,000 Ordinary Shares of 10 pence each in Hikma Pharmaceuticals PLC. 
c)
Price(s) and volume(s)
Price(s): 21.22
Volume(s): 43,000
d)
Aggregated information
Aggregated volume: 43,000
Price: 21.22
e)
Date of the transaction
20 to 22 March 2017
f)
Place of the transaction
London Stock Exchange (XLON)
Peter Speirs, Company Secretary, Responsible for releasing this announcement
23 March 2017

This information is provided by RNS
The company news service from the London Stock Exchange
  END
DSHGCGDXCDDBGRX